Novo Nordisk Sees Retail Buying Despite Wall Street Cuts

Mitrade
Updated
coverImg
Source: DepositPhotos

Insights – Shares of leading weight-loss drugmaker Novo Nordisk plunged after disappointing results from its latest weight-loss drug trial. Despite analysts slashing their price targets, retail investors flooded into the stock with massive buy-the-dip activity.  


According to data from Vanda Research, retail inflows into Novo Nordisk surged 32-fold on Friday, December 20. The single-day net inflow jumped from $490,000 the previous day to $15.6 million.  


Marco Iachini, Senior Vice President at Vanda Research, noted that retail investors tend to buy the dip, particularly in popular stocks, and added that they would continue doing so until the strategy ceased to be effective.


Novo Nordisk’s December 20 trial results revealed that its next-generation weight-loss drug, CagriSema, achieved only a 22.7% weight loss effect after eight weeks of treatment, falling short of the market expectation of 25%.  


The company’s previous flagship weight-loss drug, Wegovy, had set high standards, and Novo Nordisk had hoped CagriSema would outperform its main competitor, Eli Lilly’s (LLY.US) Zepbound. However, the underwhelming trial results sent Novo Nordisk shares tumbling 17.83% on the day, while Eli Lilly’s stock ended a multi-day decline, rising 1.35%.  


Following the trial results, Wall Street analysts sharply lowered their price targets for Novo Nordisk.BMO Capital** cut its target from $156 to $105.  TD Cowen** reduced its target from $155 to $105.  Jefferies downgraded its target to $81.50 and maintained a "Sell" rating.  


As of the latest close, Novo Nordisk shares traded at $87.37, representing a year-to-date decline of 15.54%.  




* The content presented above, whether from a third party or not, is considered as general advice only.  This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.

goTop
quote
Do you find this article useful?
Related Articles
placeholder
S&P 500 loses $1.5 trillion after Trump threatened new China tariffsThe Dow tanked nearly 900 points on Friday as markets completely flipped after President Donald Trump threatened fresh tariffs on Chinese goods.
Author  Cryptopolitan
22 hours ago
The Dow tanked nearly 900 points on Friday as markets completely flipped after President Donald Trump threatened fresh tariffs on Chinese goods.
placeholder
Intel’s Make-or-Break Moment: First 18A Chip Debut Sets Stage for ComebackOn Thursday, October 9, Intel revealed key details of its first-ever 18A-process chip, marking a breakthrough in producing the most advanced semiconductor technology in the United States.
Author  TradingKey
Yesterday 07: 58
On Thursday, October 9, Intel revealed key details of its first-ever 18A-process chip, marking a breakthrough in producing the most advanced semiconductor technology in the United States.
placeholder
Coinbase, Mastercard compete to acquire stablecoin firm BVNK in $2 billion dealCoinbase and Mastercard are reportedly competing to acquire stablecoin infrastructure firm BVNK in a deal valued at about $2 billion.
Author  FXStreet
Yesterday 05: 49
Coinbase and Mastercard are reportedly competing to acquire stablecoin infrastructure firm BVNK in a deal valued at about $2 billion.
placeholder
OpenAI’s Sora reaches 1m downloads outpacing ChatPGTOpenAI’s video generating app, Sora surged to one million downloads in under five days after its launch.
Author  Cryptopolitan
Yesterday 01: 17
OpenAI’s video generating app, Sora surged to one million downloads in under five days after its launch.
placeholder
Gold’s Surge Pulls Miners Higher, But “Fast Money” Fuels Discipline Crisis in the SectorThis week, gold prices surged past the $4,000/oz milestone, fueled by expectations of Fed rate cuts and ongoing economic and geopolitical uncertainty.
Author  TradingKey
Oct 09, Thu
This week, gold prices surged past the $4,000/oz milestone, fueled by expectations of Fed rate cuts and ongoing economic and geopolitical uncertainty.